Diode Laser Pulpotomy of Mature Permanent Molars With Irreversible Pulpitis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-10

Study Completion Date

2022-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Thirty six patients are included in this study. For each patient, a pulpotomy procedure is performed.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Clinical and Radiographic Evaluation of Low-Level Diode Laser Full Pulpotomy in Vital Permanent Teeth

NCT06176378

Irreversible Pulpitis Endodontic Inflammation

COMPLETED NA

Evaluation Of Laser Versus Conventional Pulpotomies In Mature Molar Teeth With Irreversible Pulpitis

NCT07287709

Irreversible Pulpitis (Toothache)

RECRUITING NA

Evaluation Of Different Pulpotomy Agents Used For Treatment Of Immature Molars

NCT05347160

Infected Pulp Root Canal Treatment

UNKNOWN NA

The Influence of Magnification and Clinical Experience on the Outcome of Pulpotomy in Mature Adult Teeth

NCT06231290

Irreversible Pulpitis

RECRUITING NA

Clinical and Radiographic Assessment of Nano-Bioactive Glass Combined With I-PRF Scaffold in Vital Pulp Treatments in Mandibular Molars With Closed Apices

NCT05876520

Vital Pulp Treatment in Mature Permanent Teeth With Irreversible Pulpitis

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

For each patient, a pulpotomy procedure is done. Group I (n=12) pulpotomy is performed and hemostasis is achieved by applying NaOCl, then the radicular pulp is covered with Platelet Rich Fibrin (PRF) and capped with Biodentine, Group II (n=12) pulpotomy is done as in group I and hemostasis is achieved using diode laser and remaining pulp is capped with Biodentine, Group III (n=12) pulpotomy is performed and hemostasis is achieved as in group II then radicular pulp is covered with PRF then capped with Biodentine, The teeth are then restored with Glass ionomer cement followed by composite restoration. Pain is recorded every 24 hours for 7 days after intervention. Clinical and radiographic follow-up are done at 1,3,6,9 and 12 months. Cone beam computed tomography (CBCT) is done immediate postoperative and will be used for the assessment of the outcome of the pulpotomy procedure at the end of the study period.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Irreversible Pulpitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group I: Platelet rich Fibrin (PRF) and Biodentine

Group Type EXPERIMENTAL

pulpotomy

Intervention Type PROCEDURE

coronal pulp tissue removal followed by radicular pulp hemostasis them applying a pulp capping material

Group II: Diode Laser and Biodentine

Group Type EXPERIMENTAL

pulpotomy

Intervention Type PROCEDURE

coronal pulp tissue removal followed by radicular pulp hemostasis them applying a pulp capping material

Diode laser - fonalaser

Intervention Type DEVICE

diode laser beam application

Group III: Diode laser + PRF + Biodentine

Group Type EXPERIMENTAL

pulpotomy

Intervention Type PROCEDURE

coronal pulp tissue removal followed by radicular pulp hemostasis them applying a pulp capping material

Diode laser - fonalaser

Intervention Type DEVICE

diode laser beam application

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pulpotomy

coronal pulp tissue removal followed by radicular pulp hemostasis them applying a pulp capping material

Intervention Type PROCEDURE

Diode laser - fonalaser

diode laser beam application

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients between 18 and 40 years of age.
2. Deep caries in a permanent lower molar with mature roots.
3. Clinical diagnosis of symptomatic irreversible pulpitis
4. No signs of pulpal necrosis including sinus tract or swelling.
5. Vital bleeding pulp tissue should be present in all canals after complete pulpotomy.
6. The tooth is restorable.

Exclusion Criteria

1. Patients with systemic disease.
2. Negative response to cold testing.
3. Presence of sinus tract or swelling.
4. No pulp exposure after caries excavation.
5. Bleeding could not be controlled
6. Absence of bleeding from any of the canals.
7. Teeth with radiographic signs of internal resorption.
8. Pulpal calcifications.
9. Non-restorable teeth

Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes